Endolymphatic hydrops observed at higher rate in MD than in patients with vestibular migraine, vestibular schwannoma<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, Dec. 29, 2023 (HealthDay News) — Magnetic resonance imaging (MRI) can differentiate Meniere disease (MD) from other menieriform diseases, according to a study published online Dec. 6 in Scientific Reports<\/em>.<\/p>\n Jinye Li, from Shandong University in Jinan, China, and colleagues examined the differences of imaging findings and features between MD and other menieriform diseases via intravenous gadolinium-enhanced MRI. MR images were analyzed from 426 patients with menieriform symptoms, including MD, vestibular migraine (VM), and vestibular schwannoma (VS).<\/p>\n The researchers found that patients with MD had endolymphatic hydrops (EH) at a higher rate than patients with other menieriform diseases (85.71 versus 14.75 percent [VM group] and 37.50 percent [VS group]). The MD and VM groups had significant differences in the prevalence of unilateral EH as well as cochlear and vestibular EH. The MD and VM groups also had a different prevalence of cochlear EH (I and II) and vestibular EH (II and III). A higher prevalence of perilymphatic enhancement was observed in the MD versus the VM group. Higher degrees of cochlear and vestibular hydrops were seen in the definite versus probable MD group.<\/p>\n “With obtained significant imaging differences, MRI can be considered to assist clinicians for differential diagnosis between MD and other menieriform diseases,” the authors write.<\/p>\n